Effect of selumetinib plus AZD8186 treatment on cabazitaxel sensitivity in docetaxel-acquired resistant metastatic prostate cancer cell lines

de Porras, VR; Laguia, F; Marin-Aguilera, M; Jimenez, N; Mellado, B; Ramirez, JL; Martinez-Balibrea, E; Font, A

ANNALS OF ONCOLOGY, 2019; 30 ():